The future of cancer research
Podcast in Hungarian. read more
News
What does artificial intelligence see of our cells?
Podcast in Hungarian. read more
Announcement
Turbine strengthens R&D capabilities with key appointments
Biotech entrepreneur Mark Velleca is Board Chair, seasoned cancer biology advisors Gordon Mills and Klaus Hoeflich join Scientific Advisory Board. read more
Country focus: Hungary carves out a niche in digital pharma
AI simulated cell company Turbine is just one of many digital drug discovery firms on the rise in Hungary. We speak to the company’s CEO… read more
Announcement
Turbine Raises EUR 5.7M to Advance Simulation-first Oncology Pipeline
Turbine, a company simulating cellular decision making to unlock novel oncology therapies, today announces the successful closing of its pre-Series A round by raising EUR… read more
Big pharma doesn’t like to take this kind of risk – Turbine AI raises fresh capital
Article in Hungarian. read more